| 000 | 01740 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516041805.0 | ||
| 264 | 0 | _c20111025 | |
| 008 | 201110s 0 0 eng d | ||
| 022 | _a1879-0712 | ||
| 024 | 7 |
_a10.1016/j.ejphar.2011.05.051 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDerosa, Giuseppe | |
| 245 | 0 | 0 |
_aExenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cSep 2011 |
||
| 300 |
_a251-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aBiomarkers _xmetabolism |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
| 650 | 0 | 4 | _aExenatide |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xmetabolism |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetformin _xpharmacology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeptides _xpharmacology |
| 650 | 0 | 4 |
_aSulfonylurea Compounds _xpharmacology |
| 650 | 0 | 4 |
_aVenoms _xpharmacology |
| 700 | 1 | _aPutignano, Pietro | |
| 700 | 1 | _aBossi, Antonio C | |
| 700 | 1 | _aBonaventura, Aldo | |
| 700 | 1 | _aQuerci, Fabrizio | |
| 700 | 1 | _aFranzetti, Ivano G | |
| 700 | 1 | _aGuazzini, Barbara | |
| 700 | 1 | _aTestori, Gianpaolo | |
| 700 | 1 | _aFogari, Elena | |
| 700 | 1 | _aMaffioli, Pamela | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 666 _gno. 1-3 _gp. 251-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejphar.2011.05.051 _zAvailable from publisher's website |
| 999 |
_c20903709 _d20903709 |
||